Regulation of synaptic transmission by CRF receptors

Reviews in the Neurosciences

Volumn 17, Issue 3, 2006, Pages 279-307

  Orozco Cabal, Luis ^a   Pollandt, Sebastian ^a   Liu, Jie ^a   Shinnick Gallagher, Patricia ^a   Gallagher, Joel P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Addiction; Amygdala; Cerebellum; Cocaine; CRF; CRF1; CRF2; Excitatory transmission; Lateral septum; Locus coeruleus; Neuroadaptation; Plasticity; Prefrontal cortex; Stress; VTA

Indexed keywords

CALCITONIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PARATHYROID HORMONE; SECRETIN; UROCORTIN;

ALLOSTERISM; AMINO ACID SEQUENCE; AMYGDALOID NUCLEUS; ANTIBODY LABELING; CENTRAL NERVOUS SYSTEM; CEREBELLUM; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG WITHDRAWAL; GENOMICS; HIPPOCAMPUS; HUMAN; LOCUS CERULEUS; MAMMAL; NONHUMAN; ORGAN DISTRIBUTION; PLASTICITY; POLARIZATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SEPTUM PELLUCIDUM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

EID: 33746071556     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2006.17.3.279     Document Type: Review

References (224)

1. Aguilera G, Nikodemova M, Wynn PC, Catt KJ. Corticotropin releasing hormone receptors: two decades later. Peptides 2004; 25: 319-329.
2. Aldenhoff JB, Gruol DL, Rivier J, Vale W, Siggins GR. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983; 221: 875-877.
3. Arai M, Assil IQ, Abou-Samra AB. Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 2001; 142: 446-454.
4. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiat 1999; 156: 585-588.
5. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525-557.
6. Baram TZ, Chalmers DT, Chen C, Koutsoukos Y, De Souza EB. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 1997; 770: 89-95.
7. Baram TZ, Hirsch E, Snead OC, Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 1992; 31: 488-494.
8. Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 1991; 61: 97-101.
9. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin-releasing factor (CRF) binding-protein - a novel regulator of CRF and related peptides. Front Neuroendocrinol 1995; 16: 362-382.
10. Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol Psychiat 1996; 1: 265-277.
11. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995; 378: 284-287.
12. Behan DP, Khongsaly O, Ling N, De Souza EB. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating 'free' CRF levels in human brain. Brain Res 1996; 725: 263-267.
13. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ, Gobeske KT, Sweatt JD, Manji HK, Arnsten AFT. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004; 306: 882-884.
14. Bishop GA. Neuromodulatory effects of corticotropin releasing factor on cerebellar Purkinje cells: an in vivo study in the cat. Neuroscience 1990; 39: 251-257.
15. Bishop GA. Development of a corticotropin-releasing factor-mediated effect on the firing rate of Purkinje cells in the postnatal mouse cerebellum. Exp Neurol 2002; 178: 165-174.
16. Blank T, Nijholt I, Eckart K, Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci 2002; 22: 3788-3794.
17. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 2003; 23: 700-707.
18. Bloom FE, Battenberg EL, Rivier J, Vale W. Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regul Pept 1982; 4: 43-48.
19. Bonci A, Malenka RC. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 1999; 19: 3723-3730.
20. Borsody MK, Weiss JM. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res 1996; 724: 149-168.
21. Brar BK, Chen A, Perrin MH, Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin- releasing factor (CRF) receptors 1 and 2 beta by the CRF/urocortin family of peptides. Endocrinology 2004; 145: 1718-1729.
22. Britton DR, Koob GF, Rivier J, Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 1982; 31: 363-367.
23. Brosschot JF, Pieper S, Thayer JF. Expanding stress theory: prolonged activation and perseverative cognition. Psychoneuroendocrinology 2005; 30: 1043-1049.
24. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982; 111: 928-931.
25. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929-932.
26. Brunson KL, Chen Y, Avishai-Eliner S, Baram TZ. Stress and the developing hippocampus: a double-edged sword? Mol Neurobiol 2003; 27: 121-136.
27. Brunson KL, Schultz L, Baram TZ. The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation. Brain Res Dev Brain Res 1998; 111: 119-128.
28. Cain ST, Owens MJ, Nemeroff CB. Subcellular distribution of corticotropin-releasing-factor-like immunoreactivity in rat central nervous system. Neuroendocrinology 1991; 54: 36-41.
29. Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 1989; 505: 7-11.
30. Capote HA, Flaherty L, Lichter DG. Addictions and frontal-subcortical circuits. In: Lichter DG, Cummings JL, eds. Frontal-subcotical Circuits in Psychiatric and Neurological Disorders. New York: The Guilford Press, 2001; 231-259.
31. Cassell MD, Gray TS. Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J Comp Neurol 1989; 281: 320-333.
32. Chang CL, Hsu SYT. Ancient evolution of stress-regulating peptides in vertebrates. Peptides 2004; 25: 1681-1688.
33. Charlton BG, Ferrier IN, Perry RH. Distribution of corticotropin- releasing factor-like immunoreactivity in human brain. Neuropeptides 1987; 10: 329-334.
34. Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, Rivier JE, Sawchenko PE, Vale WW. A soluble mouse brain splice variant of type 2-alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA 2005; 102: 2620-2625.
35. Chen MF, Chiu TH, Lee EH. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats. Psychoneuroendocrinology 1992; 17: 113-124.
36. Chen Y, Bender RA, Brunson KL, Pomper JK, Grigoriadis DE, Wurst W, Baram TZ. Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc Natl Acad Sci USA 2004; 101: 15782-15787.
37. Chen Y, Brunson KL, Muller MB, Cariaga W, Baram TZ. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 CRF(1)-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J Comp Neurol 2000; 420: 305-323.
38. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
39. Churchill L, Swanson CJ, Urbina M, Kalivas PW. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem 1999; 72: 2397-2403.
40. Coast GM. Neuropeptides implicated in the control of diuresis in insects. Peptides 1996; 17: 327-336.
41. Coste SC, Murray SE, Stenzel-Poore MP. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 2001; 22: 733-741.
42. Cummings S, Elde R, EHs J, Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 1983; 3: 1355-1368.
43. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002; 23: 71-77.
44. de Kloet E, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475.
45. De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995; 20: 789-819.
46. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 1985; 5: 3189-3203.
47. De Witte P. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict Behav 2004; 29: 1325-1339.
48. Denver RJ. Evolution of the corticotropin-releasing hormone signaling system and its role in stress-induced phenotypic plasticity. Ann NY Acad Sci 1999; 897: 46-53.
49. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW. Cloning and characterization of human urocortin. Endocrinology 1996; 137: 2167-2170.
50. Dong Y, Nasif FJ, Tsui JJ, Ju WY, Cooper DC, Hu XT, Malenka RC, White FJ. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents. J Neurosci 2005; 25: 936-940.
51. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990; 15: 71-100.
52. Eberly LB, Dudley CA, Moss RL. Iontophoretic mapping of corticotropin-releasing factor (CRF) sensitive neurons in the rat forebrain. Peptides 1983; 4: 837-841.
53. Eckart K, Jahn O, Radulovic J, Radulovic M, Blank T, Stiedl O, Brauns O, Tezval H, Zeyda T, Spiess J. Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels 2002; 8: 163-177.
54. Eckart K, Radulovic J, Radulovic M, Jahn O, Blank T, Stiedl O, Spiess J. Actions of CRF and its analogs. Curr Med Chem 1999; 6: 1035-1053.
55. Van Den Eede F, Van Broeckhoven C, Claes SJ. Corticotropin-releasing factor-binding protein, stress and major depression. Ageing Res Rev 2005; 4: 213-239.
56. Ehlers CL, Henriksen SJ, Wang M, Rivier J, Vale W, Bloom FE. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 1983; 278: 332-336.
57. Emoto H, Tanaka M, Koga C, Yokoo H, Tsuda A, Yoshida, M. Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav 1993; 45: 419-422.
58. Erb S, Shaham Y, Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 1998; 18: 5529-5536.
59. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J CompNeurol 1978; 180: 545-580.
60. Fischman AJ, Moldow RL. Extrahypothalamic distribution of CRF-like immunoreactivity in the rat brain. Peptides 1982; 3: 149-153.
61. Fisher LA. Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found Symp 1993; 172: 243-257.
62. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003; 6: 968-973.
63. Florio P, Imperatore A, Sanseverino F, Torricelli M, Reis FM, Lowry PJ, Petraglia F. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. J Clin Endocrinol Metab 2004; 89: 4673-4677.
64. Fox EA, Gruol DL. Corticotropin-releasing factor suppresses the after hyperpolarization in cerebellar Purkinje neurons. Neurosci Lett 1993; 149: 103-107.
65. Froc DJ, Christie BR. Corticotrophin-releasing hormone decreases synaptic transmission in rat sensorimotor cortex in vivo. Neuroscience 2005; 134: 965-973.
66. Gallagher JP, Orozco-Cabal L, Liu J, Shinnick-Gallagher P. CRF is the 'egg and chicken', whereas ACTH and corticosteroids are only 'chickens' in response to stress. Psychoneuroendocrinology 2006; 31: 142-143.
67. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science 1991; 251: 1580-1586.
68. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiat 1986; 43: 107-113.
69. Gesing A, Bilang-Bleuel A, Droste SK, Linthorst AC, Holsboer F, Reul JM. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J Neurosci 2001; 21: 4822-4829.
70. Ghasemzadeh MB, Nelson LC, Lu XY, Kalivas PW. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem 1999; 72: 157-165.
71. Goeders NE, Bienvenu OJ, De Souza EB. Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 1990; 531: 322-328.
72. Goeders NE, Guerin GF. Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 2000; 23: 577-586.
73. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiat 2002; 159: 1642-1652.
74. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41: 1-24.
75. Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002; 13: 436-444.
76. Grammatopoulos DK, Randeva HS, Levine MA, Kanellopoulou KA, Hillhouse EW. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 2001; 76: 509-519.
77. Gray JA, McNaughton N. Comparison between the behavioural effects of septal and hippocampal lesions: a review. Neurosci Biobehav Rev 1983; 7: 119-188.
78. Gulpinar MA, Yegen BC. The physiology of learning and memory: role of peptides and stress. Curr Protein Pept Sci 2004; 5: 457-473.
79. Gurkovskaya O, Goeders NE. Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Eur J Pharmacol 2001; 432: 53-56.
80. Hashimoto K, Murakami K, Hattori T, Niimi M, Fujino K, Ota Z. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal-medulla. Peptides 1984; 5: 707-711.
81. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000; 284: 592-597.
82. Heinrichs SC. Modulation of social learning in rats by brain corticotropin-releasing factor. Brain Res 2003; 994: 107-114.
83. Heinrichs SC, Koob GF. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 2004; 311: 427-440.
84. Heinrichs SC, Menzaghi F, Merlo PE, Britton KT, Koob GF. The role of CRF in behavioral aspects of stress. Ann NY Acad Sci 1995; 771: 92-104.
85. Herman JP, Prewitt CM, Cullinan WE. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 1996; 10: 371-394.
86. Hillhouse EW, Randeva H, Ladds G, Grammatopoulos D. Corticotropin- releasing hormone receptors. Biochem Soc Trans 2002; 30: 428-432.
87. Hoare SR. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 2005; 10: 417-427.
88. Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 2005; 26: 457-470.
89. Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Biochemistry (Mosc) 2004; 43: 3996-4011.
90. Hollrigel GS, Chen K, Baram TZ, Soltesz I. The proconvulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 1998; 84: 71-79.
91. Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Med 2001; 7: 605-611.
92. Hung HC, Chou CK, Chiu TH, Lee EH. CRF increases protein phosphorylation and enhances retention performance in rats. NeuroReport 1992; 3: 181-184.
93. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703.
94. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H. Urocortin expression in the human central nervous system. Clin Endocrinol (Oxf) 1999; 50: 107-114.
95. Jakab RL, Leranth C. Septum. In: Paxinos G, ed. The Rat Nervous System. New York, NY: Academic Press, 1995; 405-442.
96. Jedema HP, Grace AA. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 2004; 24: 9703-9713.
97. Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005; 45: 647-650.
98. Karteris E, Grammatopoulos DK, Randeva HS, Hillhouse EW. The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy. Mol Genet Metab 2001; 72: 287-296.
99. Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004; 44: 161-179.
100. Kitai ST, Shepard PD, Callaway JC, Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 1999; 9: 690-697.
101. Koenig R, Luthi A. Chronic treatment with CRF enhances excitatory synaptic transmission in medial prefrontal cortex slice cultures. Washington, DC: Society for Neuroscience, 2002; Abst 864.2.
102. Koob GF. Stress, corticotropin-releasing factor, and drug addiction. Ann NY Acad Sci 1999; 897: 27-45.
103. Koob GF, Bloom, FE. Corticotropin-releasing factor and behavior. Fed Proc 1985; 44: 259-263.
104. Korte SM, Koolhaas JM, Wingfield JC, McEwen BS. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev 2005; 29: 3-38.
105. Kostich WA, Chen A, Sperle K, Largent BL. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2 gamma receptor. Mol Endocrinol 1998; 12: 1077-1085.
106. Kozell LB, Meshul CK. The effects of acute or repeated cocaine administration on nerve terminal glutamate within the rat mesolimbic system. Neuroscience 2001; 106: 15-25.
107. Kozicz T. Neurons colocalizing urocortin and cocaine and amphetamine-regulated transcript immunoreactivities are induced by acute lipopolysaccharide stress in the Edinger-Westphal nucleus in the rat. Neuroscience 2003; 116: 315-320.
108. Kozicz T, Yanaihara H, Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 1998; 391: 1-10.
109. Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the super-family of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004; 103: 21-80.
110. Kumar KB, Karanth KS. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats. J Neural Transm 1996; 103: 1117-1126.
111. Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S. Pharmacological and non-pharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 2003; 28: 2169-2178.
112. Lederis K, Letter A, McMaster D, Moore G, Schlesinger D. Complete amino acid sequence of urotensin 1, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science 1982; 218: 162-165.
113. Lee EH. Corticotropin-releasing factor injected into the lateral septum improves memory function in rats. Chin J Physiol 1995; 38: 125-129.
114. Lee EH, Huang AM, Tsuei KS, Lee WY. Enhanced hippocampal corticotropin-releasing factor gene expression associated with memory consolidation and memory storage in rats. Chin J Physiol 1996; 39: 197-203.
115. Lee EH, Tsai MJ. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav Neural Biol 1989; 51: 412-423.
116. Lee EHY, Hung HC, Lu KT, Chen WH, Chen HY. Protein-synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rats. Peptides 1992; 13: 927-937.
117. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001; 98: 7570-7575.
118. Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 2002; 22: 991-1001.
119. Li Y, Hu XT, Berney TG, Vartanian AJ, Stine CD, Wolf ME, White FJ. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 1999; 34: 169-180.
120. Liu J, Yu B, Neugebauer V, Grigoriadis D, Rivier J, Vale W, Shinnick-Gallagher P, Gallagher J. Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 2004; 24: 4020-4029.
121. Liu J, Yu B, Orozco-Cabal L, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P, Gallagher JP. Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 2005; 25: 577-583.
122. Lovejoy DA, Balment RJ. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen Comp Endocrinol 1999; 115: 1-22.
123. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836-840.
124. Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 2005; 8: 212-219.
125. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005; 30: 225-242.
126. McEachern JC, Shaw CA. An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res Brain Res Rev 1996; 22: 51-92.
127. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43: 2-15.
128. McFarland K, Kalivas PW. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001; 21: 8655-8663.
129. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689-1695.
130. Miyata M, Okada D, Hashimoto K, Kano M, Ito M. Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression. Neuron 1999; 22: 763-775.
131. Montecucchi PC, Anastasi A, de Castiglione R, Erspamer V. Isolation and amino acid composition of sauvagine. An active polypeptide from methanol extracts of the skin of the South American frog Phyllomedusa sauvagei. Int J Pept Protein Res 1980; 16: 191-199.
132. Montecucchi PC, Henschen A. Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei. Int J Pept Protein Res 1981; 18: 113-120.
133. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999; 92: 281-291.
134. Mutschler NH, Miczek KA. Withdrawal from a self-administered or non-contingent cocaine binge: differences in ultrasonic distress vocalizations in rats. Psychopharmacology (Berl) 1998; 136: 402-408.
135. Mutschler NH, Miczek KA. Withdrawal from i.v. cocaine 'binges' in rats: ultrasonic distress calls and startle. Psychopharmacology (Berl) 1998; 135: 161-168.
136. Nistico G, Caroleo MC, Arbitrio M, Pulvirenti L. Corticotropin-releasing factor microinfused into the locus coeruleus produces electrocortical desynchronization and immunosuppression. Neuroimmunomodulation 1994; 1: 135-140.
137. Olschowka JA, O'Donohue TL, Mueller GP, Jacobowitz DM. The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain. Peptides 1982; 3: 995-1015.
138. Olschowka JA, O'Donohue TL, Mueller GP, Jacobowitz DM. Hypothalamic and extrahypothalamic distribution of CRF-like immunoreactive neurons in the rat brain. Neuroendocrinology 1982; 35: 305-308.
139. Orozco-Cabal L, Polland S, Liu J, Scott MT, Krishnan B, Shinnick-Gallagher P, Gallagher JP. CRF (corticotropin-releasing factor) does not have a direct effect upon excitatory synaptic transmission from BLA (basolateral amygdala) inputs to layer V-pyramidal neurons in the rat prelimbic cortex. Washington DC: The Society for Neuroscience, 2005; Abst 730.7.
140. Orozco-Cabal L Liu J, Shinnick-Gallagher P, Gallagher JP. Combined effects of CRF and dopamine on excitatory synaptic responses of layer V/VI neocortical pyramidal neurons in the rat: an in vitro study. Endocrinology Society Meeting, 2005, San Diego, CA, Abst P3-20.
141. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991; 43: 425-473.
142. Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci Lett 1993; 164: 81-84.
143. Palkovits M, Brownstein MJ, Vale W. Distribution of corticotropin- releasing factor in rat brain. Fed Proc 1985; 44: 215-219.
144. rd. Corticotropin-releasing factor in the olivocerebellar tract of rats: demonstration by light- and electron-microscopic immunohistochemistry and in situ hybridization histochemistry. Proc Natl Acad Sci USA 1987; 84: 3911-3915.
145. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1998.
146. Perrin MH, Sutton S, Bain DL, Berggren WT, Vale WW. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. Endocrinology 1998; 139: 566-570.
147. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 1999; 885: 312-328.
148. Petraglia F, Florio P, Benedetto C, Gallo C, Woods RJ, Genazzani AR, Lowry PJ. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J Clin Endocrinol Metab 1996; 81: 852-856.
149. Pickens R, Thompson T. Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size. J Pharmacol Exp Ther 1968; 161: 122-129.
150. Pieretti S, Ortolani E, Di Giannuario A, Loizzo A. Effects of endorphin derivatives on the EEG alterations induced by corticotropin releasing factor in the rabbit hippocampus. Pharmacol Res 1990; 22: 627-633.
151. Pisarchik A, Slominski AT. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 2001; 15: 2754-2756.
152. Pitkanen A, Savander M, Nurminen N, Ylinen A. Intrinsic synaptic circuitry of the amygdala. Ann NY Acad Sci 2003; 985: 34-49.
153. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 1991; 349: 423-426.
154. Primus RJ, Yevich E, Baltazar C, Gallager DW. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 1997; 17: 308-316.
155. Quirk GJ, Gehlert DR. Inhibition of the amygdala: key to pathological states? Ann NY Acad Sci 2003; 985: 263-272.
156. Radulovic J, Ruhmann A, Liepold T, Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 1999; 19: 5016-5025.
157. Rainnie DG, Fernhout BJH, Shinnick-Gallagher P. Differential actions of corticotropin releasing-factor on basolateral and central amygdaloid neurons, in vitro. J Pharmacol Exp Ther 1992; 263: 846-858.
158. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004; 24: 3471-3479.
159. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001; 98: 2843-2848.
160. Richter RM, Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999; 32: 254-261.
161. Richter RM, Pich EM, Koob GF, Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 1995; 187: 169-172.
162. Rivier C, Lee S. Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus. Mol Cell Neurosci 1994; 5: 189-195.
163. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol 2003; 54: 25-53.
164. Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003; 37: 577-582.
165. Sakanaka M, Shibasaki T, Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 1987; 260: 256-298.
166. Sarnyai Z. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans. Ann NY Acad Sci 1998; 851: 371-387.
167. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 1993; 616: 315-319.
168. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res 1995; 675: 89-97.
169. Sarnyai Z, Hohn J, Szabo G, Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci 1992; 51: 2019-2024.
170. Sauvage M, Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 2001; 104: 643-652.
171. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947-950.
172. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W. The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 1993; 172: 5-21.
173. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. 1957. J Neuropsychiatry Clin Neurosci 2000; 12: 103-113.
174. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74: 1-58.
175. Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002; 366: 381-416.
176. Selye H. The Stress of Life. New York, NY: McGraw Hill, 1976.
177. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor(1) receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 1998; 137: 184-190.
178. Sheehan TP, Chambers RA, Russell DS. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 2004; 46: 71-117.
179. Siggins GR, Gruol D, Aldenhoff J, Pittman Q. Electrophysiological actions of corticotropin-releasing factor in the central nervous system. Fed Proc 1985; 44: 237-242.
180. Singewald N, Zhou GY, Chen F, Philippu A. Corticotropin-releasing factor modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats. Neurosci Lett 1996; 204: 45-48.
181. Sirinathsinghji DJ, Rees LH, Rivier J, Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983; 305: 232-235.
182. Skofitsch G, Jacobowitz DM. Distribution of corticotropin releasing factor-like immunoreactivity in the rat brain by immunohistochemistry and radioimmunoassay: comparison and characterization of ovine and rat/ human CRF antisera. Peptides 1985; 6: 319-336.
183. Smith BN, Dudek FE. Age-related epileptogenic effects of corticotropin-releasing hormone in the isolated CA1 region of rat hippocampal slices. J Neurophysiol 1994; 72: 2328-2333.
184. Smith MA, Weiss RB, Berry L, Zhang LX, Clark M, Massenburg G, Post M. Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res 1997; 745: 248-256.
185. Spiess J, Rivier J, Rivier C, Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 1981; 78: 6517-6521.
186. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of Life Stress, Cognition and Health. New York, NY: John Wiley and Sons, 1988; 629-649.
187. Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982; 297: 331-333.
188. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983; 36: 165-186.
189. Swinny JD, Kalicharan D, Blaauw EH, Ijkema-Paassen J, Shi F, Gramsbergen A, van der Want JJ. Corticotropin-releasing factor receptor types 1 and 2 are differentially expressed in pre- and post-synaptic elements in the post-natal developing rat cerebellum. Eur J Neurosci 2003; 18: 549-562.
190. Swinny JD, Kalicharan D, Gramsbergen A, van der Want JJ. The localisation of urocortin in the adult rat cerebellum: a light and electron microscopic study. Neuroscience 2002; 114: 891-903.
191. Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T. Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 1998; 19: 643-647.
192. Tan H, Zhong P, Yan Z. Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 2004; 24: 5000-5008.
193. Tazi A, Swerdlow NR, LeMoal M, Rivier J, Vale W, Koob GF. Behavioral activation by CRF: evidence for the involvement of the ventral forebrain. Life Sci 1987; 41: 41-49.
194. Thompson RC, Seaholtz AF, Douglas JO. Cloning and distribution of the rat corticotropin-releasing factor (CFR) gene. In: De Souza EB, Nemeroff CB, eds. Basic and Clinical Studies of the Neuropeptides. Boca Raton, FL: CRC Press, 1990; 1-12.
195. Tian JB, Bishop GA. Frequency-dependent expression of corticotropin releasing factor in the rat's cerebellum. Neuroscience 2003; 121: 363-377.
196. Turnbull AV, Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 1997; 215: 1-10.
197. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 2003; 39: 401-407.
198. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J. Chemical and biological characterization of CRF. Rec Prog Horm Res 1983; 39: 245-267.
199. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
200. Valentine RJ, Foote SL. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 1988; 8: 1016-1025.
201. Valentino RJ, Martin DL, Suzuki M. Dissociation of locus coeruleus activity and blood pressure. Effects of clonidine and corticotropin-releasing factor. Neuropharmacology 1986; 25: 603-610.
202. Valentino, RJ, Page, ME, Curtis, AL. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 1991; 555: 25-34.
203. Valentino RJ, Rudoy C, Saunders A, Liu X-B, Van Bockstaele EJ. Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the perilocus coeruleus region. Neuroscience 2001; 106: 375-384.
204. Valentino R, Foote S. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology 1987; 45: 28-36.
205. Valentino R, Foote S, Page M. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 1993; 697: 173-188.
206. Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav 2001; 73: 273-283.
207. Van Bockstaele EJ, Colago EE, Valentino RJ. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 1996; 364: 523-534.
208. Van Gaalen MM, Stenzel-Poore M, Holsboer F, Steckler T. Reduced attention in mice overproducing corticotropin-releasing hormone. Behav Brain Res 2003; 142: 69-79.
209. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
210. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin-I and to corticotropin-releasing factor. 1995; 378: 287-292.
211. Vermetten E, Bremner JD. Circuits and systems in stress. I. Preclinical studies. Depress Anxiet 2002; 15: 126-147.
212. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. Cocaine experience establishes control of raid-brain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 2005; 25: 5389-5396.
213. Wang HL, Tsai LY, Lee EH. Corticotropin-releasing factor produces a protein synthesis-dependent long-lasting potentiation in dentate gyrus neurons. J Neurophysiol 2000; 83: 343-349.
214. Wang HL, Wayner MJ, Chai CY, Lee EH. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci 1998; 10: 3428-3437.
215. Waselus M, Valentino RJ, Van Bockstaele EJ. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol 2005; 482: 155-165.
216. Weiss SR, Post RM, Gold PW, Chrousos G, Sullivan TL, Walker D, Pert A. CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res 1986; 372: 345-351.
217. Wise RA. Addiction becomes a brain disease. Neuron 2000; 26: 27-33.
218. Wolter HJ. Corticotropin-releasing factor: immunohistochemical colocalization with adrenocorticotropin and beta-endorphin, but not with Met-enkephalin, in subpopulations of duodenal perikarya of rat. Biochem Biophys Res Commun 1985; 128: 402-410.
219. Woods J. Behavioral effects of cocaine in animals. NIDA Res Monogr 1977; 13: 63-95.
220. Yan XX, Baram TZ, Gerth A, Schultz L, Ribak CE. Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons. Exp Brain Res 1998; 123: 334-340.
221. Van XX, Toth Z, Schultz L, Ribak CE, Baram TZ. Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus 1998; 8: 231-243.
222. Yu B, Shinnick-Gallagher P. Corticotropin-releasing factor increases dihydropyridine- and neurotoxin-resistant calcium currents in neurons of the central amygdala. J Pharmacol Exp Ther 1998; 284: 170-179.
223. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"- pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 1996; 279: 351-358.
224. Zorrilla EP, Schulteis G, Ormsby A, Klaassen A, Ling N, McCarthy JR, Koob GF, De Souza EB. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors. Brain Res 2002; 952: 200-210.